Inhaled Nitric Oxide Therapy for Acute Respiratory Failure

作者: William E. Hurford , Wolfgang Steudel , Warren M. Zapol

DOI: 10.1007/978-1-4612-1326-0_10

关键词: Pulmonary hypertensionInternal medicinePulmonary arteryAcute respiratory failureNitric oxideProstaglandinARDSMedicineCardiologyVasodilationProstacyclin

摘要: Pulmonary hypertension and severe hypoxemia complicate the care of patients with diseases such as acute respiratory distress syndrome (ARDS). Numerous vasodilator therapies aimed at reducing pulmonary have been tested in these patients. All currently available intravenous vasodilators produce systemic vasodilation hypotension dosages sufficient to reduce artery pressure. In addition, infusions nitroprusside or prostacyclin (prostaglandin I2; PGI2) markedly increase venous admixture (Radermacher et al. 1990). 1991, inhaled nitric oxide (NO) was reported selectively vasodilate circulation (Fratacci 1991; Frostell 1991). The use this novel therapy an adjunct treatment ARDS has attracted immense interest.

参考文章(242)
Long Ss, Toddler-to-mother transmission of varicella-vaccine virus: how bad is that? The Journal of Pediatrics. ,vol. 131, pp. 10- 12 ,(1997)
A. Holzmann, K. D. Bloch, L. S. Sanchez, G. Filippov, W. M. Zapol, Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. American Journal of Physiology-lung Cellular and Molecular Physiology. ,vol. 271, ,(1996) , 10.1152/AJPLUNG.1996.271.6.L981
N Kieler-Jensen, A Wennmalm, C H Bergh, F Waagstein, S E Ricksten, B Lindelöv, O Stenqvist, S Lundin, Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Journal of Heart and Lung Transplantation. ,vol. 13, pp. 366- 375 ,(1994)
R. Phillip Dellinger, Janice L. Zimmerman, Robert W. Taylor, Richard C. Straube, David L. Hauser, Gerard J. Criner, Kenneth Davis, Thomas M. Hyers, Peter Papadakos, Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome : Results of a randomized phase II trial Critical Care Medicine. ,vol. 26, pp. 15- 23 ,(1998) , 10.1097/00003246-199801000-00011
K K Nobuhara, J M Wilson, Pathophysiology of congenital diaphragmatic hernia. Seminars in Pediatric Surgery. ,vol. 5, pp. 234- 242 ,(1996)
T. J. McMahon, L. J. Ignarro, P. J. Kadowitz, Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed Journal of Applied Physiology. ,vol. 74, pp. 1704- 1711 ,(1993) , 10.1152/JAPPL.1993.74.4.1704
G. Freeman, S. C. Crane, N. J. Furiosi, R. J. Stephens, M. J. Evans, W. D. Moore, Covert Reduction in Ventilatory Surface in Rats During Prolonged Exposure to Subacute Nitrogen Dioxide1,2 American Review of Respiratory Disease. ,vol. 106, pp. 563- 579 ,(1972) , 10.1164/ARRD.1972.106.4.563
D. M. Guidot, M. J. Repine, B. M. Hybertson, J. E. Repine, Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. American Journal of Physiology. ,vol. 269, ,(1995) , 10.1152/AJPLUNG.1995.269.1.L2
Paul Kubes, Samina Kanwar, Xiao‐Fei Niu, Jeffrey P. Gaboury, Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. The FASEB Journal. ,vol. 7, pp. 1293- 1299 ,(1993) , 10.1096/FASEBJ.7.13.8405815